DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Income | ₹2,461 Cr | ₹2,227 Cr | ₹2,017 Cr | ₹2,087 Cr | ₹1,581 Cr |
What is the latest Revenue of DR LAL PATHLABS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,461 Cr |
| Mar2025 | ₹2,227 Cr |
| Mar2024 | ₹2,017 Cr |
| Mar2023 | ₹2,087 Cr |
| Mar2022 | ₹1,581 Cr |
How is Revenue of DR LAL PATHLABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,461 Cr | 10.54 | |
| Mar2025 | ₹2,227 Cr | 10.40 | |
| Mar2024 | ₹2,017 Cr | -3.38 | |
| Mar2023 | ₹2,087 Cr | 32.01 | |
| Mar2022 | ₹1,581 Cr | - | |
Compare Revenue of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹28,372.2 Cr | 0.4% | 7.8% | 22.3% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹127,128.0 Cr | -0.6% | 4.2% | 16.9% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹107,853.0 Cr | -2.2% | 9.7% | -15.4% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹73,083.7 Cr | -1.2% | -2.1% | 19.7% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹41,882.3 Cr | 2.3% | -0.5% | 24.4% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹41,417.8 Cr | 1.3% | 6.3% | -0.9% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 0.4% |
7.8% |
22.3% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses